LISDEXAMFETAMINE DIMESYLATE
Active substance: lisdexamfetamine dimesylate
CAPSULE · LISDEXAMFETAMINE DIMESYLATE 50 mg/1
United StatesActive
Marketing holder: Camber Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- LISDEXAMFETAMINE DIMESYLATE · 50 mg/1
Import and control
Control by country
- United StatescontrolledSchedule: CII
Source: openFDA NDC · record 01a1208c-293a-7999-9e2a-a1a5cd0fb166,01a1208c-2caa-792f-bad2-0404b65e2c9c,01a1208c-3bef-7760-8cc3-8709eb3849e0,01a1208c-3bfb-7548-80c6-5ef89ffe94f3,01a1208c-5bc1-77a7-8c32-d06178eb71c2;count=178 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 31722-354
- Registration status
- Active
- Dispensing
- Prescription only
- Control marker
- CII
- Route
- ORAL
Sources
- product · openFDA NDC · 31722-354 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 31722-354 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 31722-354 · Verified 2026-10-09 · open in source